Dear All, 

You and your colleagues are cordially invited to register for the hybrid 2022 Technology Showcase on September 7. This annual event, planned by the National Cancer Institute’s Technology Transfer Center, in partnership with the Frederick National Laboratory (FNL), is designed to encourage licensing and collaboration of select NCI and FNL inventions. Companies, entrepreneurs, innovators, foundations, philanthropies, economic development entities, trade associations and those interested in biotechnology development are encouraged to attend!

 

Register below.

  

2022 Technology Showcase, National Cancer Institute, Frederick National Laboratory

September 7


AGENDA at a GLANCE:

11:30 AM - In-person check-in /
Join online

12:00 PM, ET U.S.
WELCOME & KEYNOTE

TECHNOLOGY PRESENTATIONS, SESSION 1

PANEL SESSIONS, SET 1 (breakout)

Panel 1: “How Collaborators Can Tap into Laboratory Resources at the Frederick National Laboratory”

Panel 2: “Government and Venture Funding”

LIGHTNING PITCH presented by NCI Technology Transfer Ambassadors Program (TTAP)

NETWORKING & POSTER SESSION (TTAP) 
in-person and virtual poster presentations

TECHNOLOGY PRESENTATIONS, SESSION 2

PANEL SESSIONS, SET 2 (breakout)

Panel 3: “Non-traditional and Foundation Sources of Support”

Panel 4: “How to Work with the NCI”


IN-PERSON NETWORKING EVENT

Independently sponsored networking event nearby without involving any resources of the Department of Health and Human Services


Be There. In person meetings are back, and virtual meetings aren't going away. A hybrid event

HOW TO ATTEND:

IN-PERSON @
Frederick National Laboratory
Advanced Technology Research Facility (ATRF)
8560 Progress Dr., Frederick, MD
or VIRTUAL


LEARN MORE: 
2022 Technology Showcase


 

Registration

 


KEYNOTE PRESENTER:

Douglas Lowy, M.D., NCI Acting Director

Douglas R. Lowy, M.D.,
NCI Acting Director


FEATURED INVENTORS:

  • John Brognard, Ph.D., Senior Investigator, NCI CCR, Laboratory of Cell and Developmental Signaling
  • Claire Deleage, Ph.D., Scientist, AIDS and Cancer Virus Program Program, FNL
  • James Gulley, M.D., Ph.D.,
    NCI CCR, Co-Director, Center for Immuno-Oncology
  • Marina A. Dobrovolskaia, Ph.D., M.B.A., P.M.P.
    Laboratory Co-Director, Director of Operations, Immunology Section at the Nanotechnology Characterization Laboratory, FNL
  • Rosandra Kaplan, M.D., Senior Investigator, Pediatric Oncology Branch, NCI CCR
  • Uma Mudunuri, Ph.D., NCI Frederick, Director, Advanced Biomedical Computational Science (ABCS)
  • Dwight V. Nissley, Ph.D., Director, Cancer Research Technology Program, FNL
  • Steven Pavletic, M.D., M.S., NCI CCR, Senior Clinician, Immune Deficiency Cellular Therapy Program
  • Eric Stahlberg, Ph.D.,
    Director, Cancer Data Science Initiatives, FNL
  • Stephan Stern, Ph.D., D.A.B.T. 
    Director of Research & Development, Head of Pharmacology & Toxicology Section, Nanotechnology Characterization Laboratory, Cancer Research Technology Program, FNL
  • Ismail Baris Turkbey, M.D., Senior Clinician, Molecular Imaging Branch, Center for Immuno-oncology, NCI CCR

 

  

About the Event

The 2022 Technology Showcase is a free, half-day event planned for September 7. It will highlight collaboration opportunities and showcase technologies being developed at the NCI and the FNL to encourage start-up company formation, technology licensing and partnerships. Attendees can choose to attend in person or online.

 

 

 

This email was sent to Email Address using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

GovDelivery logo